A

Researcher Profile

Anna Słowińska

2

Publications

755

Citations

10

Co-Authors

2

Active Years

Publications

Open Access Journal Article Annals of Oncology Dec 01, 2022

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

C.E. Geyer · J.E. Garber · R.D. Gelber · G. Yothers +562 more

10.1016/j.annonc.2022.09.159 394 citations

Open Access Journal Article The Lancet Oncology May 01, 2021

Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial

Andrés Poveda · Anne Floquet · Jonathan A Ledermann · Rebecca Asher +107 more

10.1016/s1470-2045(21)00073-5 361 citations

Publication Timeline

2022

1

2021

1

Frequent Co-Authors

Alain Lortholary

Tomasz Huzarski

Tjoung-Won Park-Simon

Michael Friedlander

Josefina Cruz Jurado

Hideko Yamauchi

Reshma L. Mahtani